Is a complete BVMF/GILD34 research report available?

No complete published report is available for bvmf/GILD34 (BVMF/GILD34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/GILD34 (BVMF/GILD34)

Brazil Stock Exchange: BVMF/GILD34 · BRL

R$70.8

-0.67 (-0.9%)· Recorded snapshot

Market cap	1.1T
Revenue (ttm)	157.8B
Net income (ttm)	-16.8B
EPS (ttm)	-R$1.17
P/E (forward)	18.7x
Dividend	R$0.96 (1.36%)
Volume	146
Beta	0.33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 157.8B
Net income (ttm): -16.8B
EPS (ttm): -R$1.17
P/E (forward): 18.7x
Market cap: 1.1T

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-29
Employees	17,000
Employees change	-400
Employees growth	-2.22%
Enterprise value	BRL 1.2T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1987
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRGILDBDR000
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2026-08-17
Last stock split type	Forward
Market cap	BRL 1.1T
Next earnings date	2026-10-29
Price	BRL 70.79
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bvmf/GILD34
Website	https://www.gilead.com

Metric

Value

Amount currency

BRL

Country

United States

Country code

Earnings date

2026-10-29

Employees

17,000

Employees change

-400

Employees growth

-2.22%

Enterprise value

BRL 1.2T

Exchange

Brazil Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1987

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

BRGILDBDR000

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split date

2026-08-17

Last stock split type

Forward

Market cap

BRL 1.1T

Next earnings date

2026-10-29

Price

BRL 70.79

Price currency

BRL

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-27

Symbol

bvmf/GILD34

Website

https://www.gilead.com

Metric	Value
Average P/E ratio (10Y)	75.16x
Average P/E ratio (3Y)	133.64x
Average P/E ratio (5Y)	84.97x
Earnings yield	-1.65%
EV/EBIT	18.46x
EV/EBITDA	14.8x
EV/FCF	17.43x
EV/Sales	7.18x
FCF / EV yield	5.74%
FCF yield	6.36%
Forward P/E	18.73x
P/(FCF - SBC) ratio	16.92x
P/(OCF - SBC) ratio	16.1x
P/B ratio	17.33x
P/FCF ratio	15.73x
P/OCF ratio	15.02x
P/S ratio	6.68x
Price/EBITDA ratio	13.94x
Sector forward P/E	11.33x
Sector P/E	41.97x

Metric

Value

Average P/E ratio (10Y)

75.16x

Average P/E ratio (3Y)

133.64x

Average P/E ratio (5Y)

84.97x

Earnings yield

-1.65%

EV/EBIT

18.46x

EV/EBITDA

14.8x

EV/FCF

17.43x

EV/Sales

7.18x

FCF / EV yield

5.74%

FCF yield

6.36%

Forward P/E

18.73x

P/(FCF - SBC) ratio

16.92x

P/(OCF - SBC) ratio

16.1x

P/B ratio

17.33x

P/FCF ratio

15.73x

P/OCF ratio

15.02x

P/S ratio

6.68x

Price/EBITDA ratio

13.94x

Sector forward P/E

11.33x

Sector P/E

41.97x

Metric	Value
EBIT margin	38.88%
EBITDA margin	47.94%
FCF margin	41.13%
Gross margin	79.6%
Operating margin	38.88%
Pretax margin	-6.42%
Profit margin	-10.64%
Profit per employee	BRL -987,400
Profitable years	19
Revenue per employee	BRL 9.3M
ROA	14.09%
ROA (5Y)	10.85%
ROCE	30.88%
ROE	-20.68%
ROE (5Y)	24.33%
ROIC	34.37%
ROIC (5Y)	21.93%
SBC / revenue	2.98%
Tax / revenue	4.22%

Metric

Value

EBIT margin

38.88%

EBITDA margin

47.94%

FCF margin

41.13%

Gross margin

79.6%

Operating margin

38.88%

Pretax margin

-6.42%

Profit margin

-10.64%

Profit per employee

BRL -987,400

Profitable years

Revenue per employee

BRL 9.3M

ROA

14.09%

ROA (5Y)

10.85%

ROCE

30.88%

ROE

-20.68%

ROE (5Y)

24.33%

ROIC

34.37%

ROIC (5Y)

21.93%

SBC / revenue

2.98%

Tax / revenue

4.22%

Metric	Value
EPS growth years	1
FCF growth	38.15%
FCF growth (Q)	376.81%
FCF growth (QoQ)	41.45%
FCF growth 3Y	13.19%
FCF growth 5Y	8.85%
Gross profit growth	6.96%
Gross profit growth (Q)	11.52%
Gross profit growth 3Y	3.69%
Gross profit growth 5Y	1.75%
Net income growth years	1
OCF growth	37.33%
OCF growth (Q)	332.04%
OCF growth (QoQ)	40.45%
OCF growth 10Y	-2.84%
OCF growth 3Y	12.52%
OCF growth 5Y	8.31%
Operating income growth	7.34%
Operating income growth (Q)	-5.23%
Operating income growth 3Y	6.62%
Operating income growth 5Y	-1.1%
Revenue growth	5.52%
Revenue growth (Q)	10.18%
Revenue growth (QoQ)	12.11%
Revenue growth 10Y	-0.61%
Revenue growth 3Y	3.61%
Revenue growth 5Y	2.72%
Revenue growth quarters	5
Revenue growth years	2

Metric

Value

EPS growth years

FCF growth

38.15%

FCF growth (Q)

376.81%

FCF growth (QoQ)

41.45%

FCF growth 3Y

13.19%

FCF growth 5Y

8.85%

Gross profit growth

6.96%

Gross profit growth (Q)

11.52%

Gross profit growth 3Y

3.69%

Gross profit growth 5Y

1.75%

Net income growth years

OCF growth

37.33%

OCF growth (Q)

332.04%

OCF growth (QoQ)

40.45%

OCF growth 10Y

-2.84%

OCF growth 3Y

12.52%

OCF growth 5Y

8.31%

Operating income growth

7.34%

Operating income growth (Q)

-5.23%

Operating income growth 3Y

6.62%

Operating income growth 5Y

-1.1%

Revenue growth

5.52%

Revenue growth (Q)

10.18%

Revenue growth (QoQ)

12.11%

Revenue growth 10Y

-0.61%

Revenue growth 3Y

3.61%

Revenue growth 5Y

2.72%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	BRL -3.2B
Depreciation and amortization	BRL 14.8B
EBIT	BRL 61.3B
EBITDA	BRL 75.6B
EPS	BRL -1.17
Financing cash flow	BRL -24.1B
Free cash flow	BRL 67.1B
Free cash flow minus SBC	BRL 62.3B
Gross profit	BRL 125.6B
Income taxes	BRL 6.7B
Investing cash flow	BRL -56.2B
Net borrowing	BRL 6.9B
Net cash flow	BRL -10.2B
Net income	BRL -16.8B
Operating cash flow minus SBC	BRL 65.5B
Operating income	BRL 61.3B
Revenue	BRL 157.8B
Stock-based compensation	BRL 4.7B

Metric

Value

Capital expenditures

BRL -3.2B

Depreciation and amortization

BRL 14.8B

EBIT

BRL 61.3B

EBITDA

BRL 75.6B

EPS

BRL -1.17

Financing cash flow

BRL -24.1B

Free cash flow

BRL 67.1B

Free cash flow minus SBC

BRL 62.3B

Gross profit

BRL 125.6B

Income taxes

BRL 6.7B

Investing cash flow

BRL -56.2B

Net borrowing

BRL 6.9B

Net cash flow

BRL -10.2B

Net income

BRL -16.8B

Operating cash flow minus SBC

BRL 65.5B

Operating income

BRL 61.3B

Revenue

BRL 157.8B

Stock-based compensation

BRL 4.7B

Metric	Value
Altman Z-Score	4.05
Book value per share	BRL 49.38
Debt / EBITDA	1.78
Debt / equity	2.23
Debt / FCF	2.03
Goodwill	BRL 44.5B
Interest coverage	11.86
Long-term assets	BRL 181.1B
Long-term liabilities	BRL 135.9B
Net cash (debt)	BRL -110.7B
Net cash / market cap	-10.49%
Net debt / EBITDA	1.46
Net debt / equity	1.82
Net debt / FCF	1.65
Piotroski F-Score	5
Property, plant and equipment	BRL 31.2B
Shareholders' equity	BRL 60.8B
Tangible book value	BRL -54.5B
Tangible book value per share	BRL -43.91
Total assets	BRL 255.7B
Total cash	BRL 25.3B
Total debt	BRL 136B
Total liabilities	BRL 194.9B
WACC	5.73%

Metric

Value

Altman Z-Score

4.05

Book value per share

BRL 49.38

Debt / EBITDA

1.78

Debt / equity

2.23

Debt / FCF

2.03

Goodwill

BRL 44.5B

Interest coverage

11.86

Long-term assets

BRL 181.1B

Long-term liabilities

BRL 135.9B

Net cash (debt)

BRL -110.7B

Net cash / market cap

-10.49%

Net debt / EBITDA

1.46

Net debt / equity

1.82

Net debt / FCF

1.65

Piotroski F-Score

Property, plant and equipment

BRL 31.2B

Shareholders' equity

BRL 60.8B

Tangible book value

BRL -54.5B

Tangible book value per share

BRL -43.91

Total assets

BRL 255.7B

Total cash

BRL 25.3B

Total debt

BRL 136B

Total liabilities

BRL 194.9B

WACC

5.73%

Metric	Value
Asset turnover	0.58
Current assets	BRL 74.6B
Current liabilities	BRL 59B
Current ratio	1.27
Inventory turnover	3.29
Net working capital	BRL 2.4B
Quick ratio	0.9
Working capital	BRL 15.2B
Working capital turnover	48.9

Metric

Value

Asset turnover

0.58

Current assets

BRL 74.6B

Current liabilities

BRL 59B

Current ratio

1.27

Inventory turnover

3.29

Net working capital

BRL 2.4B

Quick ratio

0.9

Working capital

BRL 15.2B

Working capital turnover

48.9

Metric	Value
Buyback yield / dilution	1.39%
Dividend growth	-4.27%
Dividend growth (3Y)	4.16%
Dividend growth (5Y)	2.66%
Dividend growth years	2
Dividend payment date	2026-10-05
Dividend payment years	11
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.96
Dividend yield	1.36%
Ex-dividend date	2026-09-14
Last dividend	BRL 0.24
Shareholder yield	2.75%

Metric

Value

Buyback yield / dilution

1.39%

Dividend growth

-4.27%

Dividend growth (3Y)

4.16%

Dividend growth (5Y)

2.66%

Dividend growth years

Dividend payment date

2026-10-05

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

BRL 0.96

Dividend yield

1.36%

Ex-dividend date

2026-09-14

Last dividend

BRL 0.24

Shareholder yield

2.75%

Metric	Value
10Y price change	258.89%
10Y return CAGR	16.62%
10Y total return	365.05%
150-day SMA	BRL 59.11
1D price change	-0.94%
1M price change	9.35%
1M total return	9.35%
1W price change	9.21%
1W total return	9.21%
1Y price change	28.8%
1Y return CAGR	31%
1Y total return	30.97%
20-day SMA	BRL 64.77
200-day SMA	BRL 57.53
3M price change	28.5%
3M total return	29.01%
3Y price change	115.38%
3Y return CAGR	31.94%
3Y total return	129.74%
50-day SMA	BRL 63.54
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 73.36
52-week high date	2026-10-26
52-week low	BRL 52.08
52-week low date	2026-06-15
5Y price change	124.21%
5Y return CAGR	20.4%
5Y total return	152.93%
6M price change	22.86%
6M total return	23.91%
All-time high	BRL 73.36
All-time high date	2026-10-26
All-time low	BRL 17.05
All-time low date	2017-05-15
Average true range (ATR)	BRL 1.73
Average volume	179.7
Beta (5Y)	0.33
Change from 52-week high	-3.5%
Change from 52-week low	35.93%
Change from all-time high	-3.5%
Change from all-time low	315.24%
Change from open	1.22%
Day's gap	-2.13%
Dollar volume	BRL 10,335
High price	BRL 70.87
Low price	BRL 69.70
Monthly RSI	70.89
Open price	BRL 69.94
Position in 52-week range	93.16%
Previous close	BRL 71.46
Price vs 150-day SMA	19.76%
Price vs 20-day SMA	9.29%
Price vs 200-day SMA	23.05%
Price vs 50-day SMA	11.4%
Relative volume	0.81
RSI	67.11
Sharpe ratio	0.9
Sharpe ratio (3Y)	1.14
Sharpe ratio (5Y)	0.77
Sortino ratio	1.58
Sortino ratio (3Y)	1.95
Sortino ratio (5Y)	1.35
Volume	146
Weekly RSI	68.54
YTD price change	23.48%
YTD total return	25.01%

Metric

Value

10Y price change

258.89%

10Y return CAGR

16.62%

10Y total return

365.05%

150-day SMA

BRL 59.11

1D price change

-0.94%

1M price change

9.35%

1M total return

9.35%

1W price change

9.21%

1W total return

9.21%

1Y price change

28.8%

1Y return CAGR

31%

1Y total return

30.97%

20-day SMA

BRL 64.77

200-day SMA

BRL 57.53

3M price change

28.5%

3M total return

29.01%

3Y price change

115.38%

3Y return CAGR

31.94%

3Y total return

129.74%

50-day SMA

BRL 63.54

50-day SMA vs 200-day SMA

50over200

52-week high

BRL 73.36

52-week high date

2026-10-26

52-week low

BRL 52.08

52-week low date

2026-06-15

5Y price change

124.21%

5Y return CAGR

20.4%

5Y total return

152.93%

6M price change

22.86%

6M total return

23.91%

All-time high

BRL 73.36

All-time high date

2026-10-26

All-time low

BRL 17.05

All-time low date

2017-05-15

Average true range (ATR)

BRL 1.73

Average volume

179.7

Beta (5Y)

0.33

Change from 52-week high

-3.5%

Change from 52-week low

35.93%

Change from all-time high

-3.5%

Change from all-time low

315.24%

Change from open

1.22%

Day's gap

-2.13%

Dollar volume

BRL 10,335

High price

BRL 70.87

Low price

BRL 69.70

Monthly RSI

70.89

Open price

BRL 69.94

Position in 52-week range

93.16%

Previous close

BRL 71.46

Price vs 150-day SMA

19.76%

Price vs 20-day SMA

9.29%

Price vs 200-day SMA

23.05%

Price vs 50-day SMA

11.4%

Relative volume

0.81

RSI

67.11

Sharpe ratio

0.9

Sharpe ratio (3Y)

1.14

Sharpe ratio (5Y)

0.77

Sortino ratio

1.58

Sortino ratio (3Y)

1.95

Sortino ratio (5Y)

1.35

Volume

146

Weekly RSI

68.54

YTD price change

23.48%

YTD total return

25.01%

Metric	Value
Float	1.2B
Shares change (QoQ)	-0.88%
Shares change (YoY)	-1.39%
Shares held by insiders	0.09%
Shares held by institutions	90.91%
Short ratio	3.3 days

Metric

Value

Float

1.2B

Shares change (QoQ)

-0.88%

Shares change (YoY)

-1.39%

Shares held by insiders

0.09%

Shares held by institutions

90.91%

Short ratio

3.3 days

BVMF/GILD34 (BVMF/GILD34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/GILD34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/GILD34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/GILD34

Frequently asked questions